Page last updated: 2024-10-21

ethylisopropylamiloride and Constriction, Pathologic

ethylisopropylamiloride has been researched along with Constriction, Pathologic in 1 studies

ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.

Constriction, Pathologic: The condition of an anatomical structure's being constricted beyond normal dimensions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YX1
Ma, X1
Whitman, S1
O'brien, ER1

Other Studies

1 other study available for ethylisopropylamiloride and Constriction, Pathologic

ArticleYear
Novel antiinflammatory vascular benefits of systemic and stent-based delivery of ethylisopropylamiloride.
    Circulation, 2004, Dec-14, Volume: 110, Issue:24

    Topics: Amiloride; Animals; Anti-Inflammatory Agents; Aorta; Apolipoproteins E; Arteriosclerosis; Cell Adhes

2004